Waves of pharmaceutical product innovation require environmental monitoring approaches that can advance in lockstep with the increasing range of emerging modalities and advanced therapies.
Amid this progress, traditional environmental monitoring practices and processes are also in need of updating, with novel tools and technologies an often untapped resource. This session will discuss:
- Validating approaches for biologics, cell and gene therapies and beyond
- Assessing advanced compliance tools
- Becoming more proactive in environmental monitoring
